SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Drugs that provide the splice of life: Motor neurons relay signals from the nervous system to muscle fibers. In patients with spinal muscular atrophy, a protein required for the survival of these neurons is deficient or missing altogether, so the neurons gradually die and the patients' muscles waste away. The disease is currently untreatable. Naryshkin et al. discovered small-molecule drugs that cause cells to produce the missing protein by altering how a specific mRNA is put together, or “spliced” (see the Perspective by Vigevani and Valcárcel). When the researchers used the drugs to treat diseased mice, the mice showed marked improvement in muscle mass, motor function, and survival. Science , this issue p. 688 ; see also p. 624
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These screens, which are typically conducted in genetically engineered cell lines that harbour the target of interest, led to the discovery of the splice modulators risdiplam106 and branaplam107 for the treatment of spinal muscular atrophy”
From Human disease models in drug development (2023) · cites this paper as [106]
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
GMAP: A genomic mapping and alignment program for mRNA and EST sequences
Wu, T. D., & Watanabe, C. K. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti310 · Cited by 2,354
Fast and SNP-tolerant detection of complex variants and splicing in short reads
Wu, T. D., & Nacu, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq057 · Cited by 1,894
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Wang, C. H., Finkel, R. S., Bertini, E. S., Schroth, M., Simonds, A., Wong, B., Aloysius, A., Morrison, L., Main, M., Crawford, T. O., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305788 · Cited by 961
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Burghes, A. H. M., & Beattie, C. E. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2670 · Cited by 723
Sugarman, E. A., Nagan, N., Zhu, H., Akmaev, V. R., Zhou, Z., Rohlfs, E. M., Flynn, K., Hendrickson, B. C., Scholl, T., Sirko-Osadsa, D. A., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.134 · Cited by 661
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.18 · Cited by 650
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Passini, M. A., Bu, J., Richards, A. M., Kinnecom, C., Sardi, S. P., Stanek, L. M., Hua, Y., Rigo, F., Matson, J., Hung, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001777 · Cited by 547
The Neurobiology of Childhood Spinal Muscular Atrophy
Crawford, T. O., & Pardo, C. A. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0010 · Cited by 523
Degorce, F. (2009) · Current Chemical Genomics · doi:10.2174/1875397300903010022 · Cited by 501
Katoh, T., Sakaguchi, Y., Miyauchi, K., Suzuki, T., Kashiwabara, S.-I., Baba, T., & Suzuki, T. (2009) · Genes & Development · doi:10.1101/gad.1761509 · Cited by 440
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
Lorson, C. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.259 · Cited by 435
CLASSIFICATION OF SPINAL MUSCULAR ATROPHIES
Pearn, J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90847-8 · Cited by 422
Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2
Mailman, M. D., Heinz, J. W., Papp, A. C., Snyder, P. J., Sedra, M. S., Wirth, B., Burghes, A. H. M., & Prior, T. W. (2002) · Genetics in Medicine · doi:10.1097/00125817-200201000-00004 · Cited by 364
Wirth, B., Brichta, L., Schrank, B., Lochmüller, H., Blick, S., Baasner, A., & Heller, R. (2006) · Human Genetics · doi:10.1007/s00439-006-0156-7 · Cited by 355
The SMN complex, an assemblyosome of ribonucleoproteins
Paushkin, S., Gubitz, A. K., Massenet, S., & Dreyfuss, G. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00332-0 · Cited by 351
Self-citationBurroughs, A. M., Ando, Y., de Hoon, M. J. L., Tomaru, Y., Nishibu, T., Ukekawa, R., Funakoshi, T., Kurokawa, T., Suzuki, H., Hayashizaki, Y., et al. (2010) · Genome Research · doi:10.1101/gr.106054.110 · Cited by 350
Spinal Muscular Atrophy: A Timely Review
Kolb, S. J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.74 · Cited by 333
Determinants of Exon 7 Splicing in the Spinal Muscular Atrophy Genes, SMN1 and SMN2
Cartegni, L., Hastings, M. L., Calarco, J. A., de Stanchina, E., & Krainer, A. R. (2006) · The American Journal of Human Genetics · doi:10.1086/498853 · Cited by 306
Regulation of SMN Protein Stability
Burnett, B. G., Muñoz, E., Tandon, A., Kwon, D. Y., Sumner, C. J., & Fischbeck, K. H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01262-08 · Cited by 281
MicroRNA assassins: factors that regulate the disappearance of miRNAs
Kai, Z. S., & Pasquinelli, A. E. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1762 · Cited by 260
Singh, N. N., Singh, R. N., & Androphy, E. J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1050 · Cited by 220
Spinal muscular atrophy: The role of SMN in axonal mRNA regulation
Fallini, C., Bassell, G. J., & Rossoll, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.044 · Cited by 215
Ling, K. K. Y., Gibbs, R. M., Feng, Z., & Ko, C.-P. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr453 · Cited by 201
Self-citationThe Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing
O'Brien, K., Matlin, A. J., Lowell, A. M., & Moore, M. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805556200 · Cited by 200
Cho, S., & Dreyfuss, G. (2010) · Genes & Development · doi:10.1101/gad.1884910 · Cited by 194
Spinal Muscular Atrophy: A Clinical and Research Update
Markowitz, J. A., Singh, P., & Darras, B. T. (2012) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2011.09.001 · Cited by 188
Crawford, T. O., Paushkin, S. V., Kobayashi, D. T., Forrest, S. J., Joyce, C. L., Finkel, R. S., Kaufmann, P., Swoboda, K. J., Tiziano, D., Lomastro, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033572 · Cited by 158
Self-citationTakata, K., Shimizu, T., Iwai, S., & Wood, R. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604317200 · Cited by 156
Identification of SAP155 as the Target of GEX1A (Herboxidiene), an Antitumor Natural Product
Hasegawa, M., Miura, T., Kuzuya, K., Inoue, A., Ki, S. W., Horinouchi, S., Yoshida, T., Kunoh, T., Koseki, K., Mino, K., et al. (2010) · ACS Chemical Biology · doi:10.1021/cb100248e · Cited by 153
Younis, I., Berg, M. G., Kaida, D., Dittmar, K. A., Wang, C., & Dreyfuss, G. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01301-09 · Cited by 146
Ml, Z., Lorson, C., Androphy, E. J., & Zhou, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301550 · Cited by 140
DNA Polymerase POLN Participates in Cross-Link Repair and Homologous Recombination
Moldovan, G., Madhavan, M. V., Mirchandani, K. D., McCaffrey, R. M., Vinciguerra, P., & D’Andrea, A. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01124-09 · Cited by 128
Kuhn, A. N., van Santen, M. A., Schwienhorst, A., Urlaub, H., & Lührmann, R. (2008) · RNA · doi:10.1261/rna.1332609 · Cited by 97
Arkblad, E. L., Tulinius, M., Kroksmark, A., Henricsson, M., & Darín, N. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.01201.x · Cited by 96
A screen for regulators of survival of motor neuron protein levels
Makhortova, N. R., Hayhurst, M., Cerqueira, A., Sinor, A. D., Zhao, W., Heiser, P. W., Arvanites, A. C., Davidow, L. S., Waldon, Z., Steen, J. A. J., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.595 · Cited by 87
Self-citationSingh, N. N., Hoye, M. L., Ottesen, E. W., Upreti, D., Kaczynski, J. R., & Singh, R. N. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt609 · Cited by 86
Spinal muscular atrophy: An update on therapeutic progress
Seo, J., Howell, M. D., Singh, N. N., & Singh, R. N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.005 · Cited by 77
Chang, J., Yang, D.-M., Chang, W.-H., Chow, L., Chan, W.-L., Lin, H.-H., Huang, H.-D., Chang, Y., Hung, C.-H., & Yang, W.-K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018643 · Cited by 63
Osborne, M. A., Gomez, D., Feng, Z., McEwen, C., Beltrán, J., Cirillo, K., El‐Khodor, B. F., Lin, M.-Y., Li, Y., Knowlton, W., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds285 · Cited by 63
Self-citationAlternative splicing in spinal muscular atrophy underscores the role of an intron definition model
Singh, N. N., & Singh, R. N. (2011) · RNA Biology · doi:10.4161/rna.8.4.16224 · Cited by 61
Pathological impact of SMN2 mis‐splicing in adult SMA mice
Sahashi, K., Ling, K., Hua, Y., Wilkinson, J. E., Nomakuchi, T. T., Rigo, F., Hung, G., Xu, D. S., Jiang, Y., Lin, R. Z., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302567 · Cited by 55
Self-citationThe Regulation and Regulatory Activities of Alternative Splicing of the SMN Gene
Singh, N. N., Androphy, E. J., & Singh, R. N. (2004) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v14.i4.30 · Cited by 51
Evidence for the Involvement of Human DNA Polymerase N in the Repair of DNA Interstrand Cross-Links
Zietlow, L., Smith, L. A., Bessho, M., & Bessho, T. (2009) · Biochemistry · doi:10.1021/bi9015346 · Cited by 49
Berg, M. G., Wan, L., Younis, I., Diem, M. D., Soo, M., Wang, C., & Dreyfuss, G. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05788-11 · Cited by 43
New Therapeutic Approaches to Spinal Muscular Atrophy
Lewelt, A. J., Newcomb, T. M., & Swoboda, K. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0240-9 · Cited by 38
A novel cell immunoassay to measure survival of motor neurons protein in blood cells
Kolb, S. J., Gubitz, A. K., Olszewski, R. F., Ottinger, E. A., Sumner, C. J., Fischbeck, K. H., & Dreyfuss, G. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-6 · Cited by 33
A possible new mechanism for the control of miRNA expression in neurons
Kinjo, É. R., Higa, G. S. V., de Sousa, É., Casado, O. A. N., Damico, M. V., de Britto, L. R. G., & Kihara, A. H. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.07.022 · Cited by 23
Cited by
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
Malard, F., Wolter, A. C., Marquevielle, J., Morvan, E., Ecoutin, A., Rüdisser, S. H., Allain, F. H. T., & Campagne, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae201 · Cited by 1,273
“In recent decades, synthetic tools that enable the modulation of 5 (cid:2) -splice site selection and the correction of alternative splicing have emerged and have begun to offer therapeutics for inherited diseases ( 12–16 ).”
BackgroundScotti, M. M., & Swanson, M. S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,163
Huntington's disease: a clinical review
McColgan, P., & Tabrizi, S. J. (2018) · European Journal of Neurology · doi:10.1111/ene.13413 · Cited by 1,089
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Moffat, J. G., Vincent, F., Lee, J. A., Eder, J., & Prunotto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.111 · Cited by 939
Metadata
- Authors
- Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K. Y., Karp, G. M., Qi, H., Woll, M. G., Chen, G., Zhang, N., Gabbeta, V., Vazirani, P., Bhattacharyya, A., Furia, B., Risher, N., Sheedy, J., Kong, R., Ma, J., Turpoff, A., Lee, C.-S., Zhang, X., Moon, Y.-C., Trifillis, P., Welch, E. M., Colacino, J. M., Babiak, J., Almstead, N. G., Peltz, S. W., Eng, L. A., Chen, K. S., Mull, J. L., Lynes, M. S., Rubin, L. L., Fontoura, P., Santarelli, L., Haehnke, D., McCarthy, K. D., Schmucki, R., Ebeling, M., Sivaramakrishnan, M., Ko, C.-P., Paushkin, S. V., Ratni, H., Gerlach, I., Ghosh, A., & Metzger, F.
- Affiliations
- PTC Therapeutics (United States) (US)
- University of Southern California (US)
- Spinal Muscular Atrophy Foundation (US)
- Harvard University (US)
- F. Hoffmann-La Roche AG (CH)
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070 Basel, Switzerland.
- Corresponding author
- Peltz, Stuart W.
- Metzger, Friedrich
- ORCID
- Naryshkin, Nikolai A.
- Weetall, Marla
- Narasimhan, Jana
- Zhao, Xin
- Ling, Karen K. Y.
- Chen, Guangming
- Zhang, Nanjing
- Sheedy, Josephine
- Kong, Ronald
- Ma, Jiyuan
- Moon, Young-Choon
- Welch, Ellen M.
- Colacino, Joseph M.
- Peltz, Stuart W.
- Chen, Karen S.
- Rubin, Lee L.
- Fontoura, Paulo
- Ebeling, Martin
- Ko, Chien-Ping
- Paushkin, Sergey V.
- Ratni, Hasane
- Metzger, Friedrich
- Venue
- Science
- Published
- 2014-08-08
- Volume
- 345
- Issue
- 6197
- Pages
- 688-693
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1992985034
- Cited by
- 524
- References
- 56
- Citations by year
- 2026: 19 · 2025: 40 · 2024: 47 · 2023: 33 · 2022: 50 · 2021: 54 · 2020: 34 · 2019: 47 · 2018: 50 · 2017: 44 · 2016: 59 · 2015: 35 · 2014: 12
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- spinal muscular atrophy, SMN2, SMN1, alternative splicing, small molecules, SMN protein, motor function, lifespan extension, neuromuscular degeneration, compound screening
- MeSH terms
- Administration, Oral, Animals, Cells, Cultured, Coumarins, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Longevity, Muscular Atrophy, Spinal, Pyrimidinones, RNA, Messenger, Sequence Deletion, Alternative Splicing, Isocoumarins, Mice, Small Molecule Libraries, Survival of Motor Neuron 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.